Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - DxS Ltd (acquired by Qiagen)

September 22, 2009
QIAGEN acquires DxS Ltd – creating leadership in personalized healthcare
QIAGEN N.V. today announced that it has acquired DxS Ltd, a privately-held developer and manufacturer of companion diagnostic products headquartered in Manchester, United Kingdom. More

September 9, 2009
DxS appoints Patrik Dahlen as non-executive director
DxS Ltd, a personalised medicine company and leader in the provision of companion diagnostics, has today announced the appointment of Dr. Patrik Dahlen as non-executive director. More

September 2, 2009
DxS enters into collaboration with Bristol-Myers Squibb and ImClone Systems
DxS enters into collaboration with Bristol-Myers Squibb and ImClone Systems to provide a K-RAS companion diagnostic for ERBITUX More

August 17, 2009
DxS appoints David Jackson as vice president of business development and licensing
DxS Ltd, a personalised medicine company and leader in the provision of companion diagnostics, has today announced the appointment of Dr. David Jackson as Vice President of Business Development and Licensing. More

July 22, 2009
Horizon Discovery and DxS to lead the way in setting standards for companion diagnostic tests
Horizon Discovery and DxS announced a strategic collaboration that will see Horizon develop a panel of human isogenic cell models that recapitulate key drug sensitivity and resistance mechanisms in cancer patients that will be used to further develop DxS TheraScreen range of clinical diagnostic kits. More

July 20, 2009
DxS and Epigenomics cross-license technology for in vitro diagnostics
Both companies to use Scorpions technology for diagnostic products based on DNA methylation. More

July 13, 2009
DxS’ TheraScreen K-RAS companion diagnostic approved for use with Amgen’s Vectibix in Canada
DxS, a personalised medicine company, has had its TheraScreen: K-RAS Mutation Kit granted a licence by the regulatory body Health Canada for use as a diagnostic for anti-EGFR therapies and as the companion diagnostic for Amgens colorectal cancer therapy, Vectibix (panitumumab). More

June 22, 2009
Exosome Diagnostics and DxS collaborate to develop blood based tests for key cancer mutations
Exosome Diagnostics and DxS today announced that they will collaborate on the development of blood based companion diagnostics for key cancer gene mutations, such as KRAS, BRAF and EGFR. More

May 29, 2009
Boehringer Ingelheim and DxS sign an agreement for a companion diagnostic to identify EGFR mutations
Boehringer Ingelheim and DxS sign an agreement for a companion diagnostic to identify EGFR mutations in patients with lung cancer More

May 6, 2009
Two promotions for DxS
DxS Ltd, a personalised medicine company and leaders in the provision of companion diagnostics, has today announced the promotion of, and the appointment of Jeff Devlin, Chief Operating Officer, to the board of DxS and Peter Collins to Senior Vice President of Business Development. More

March 23, 2009
K-RAS Mutation Kit available for use in European Union on the Roche LightCycler 480 Instrument II
DxS TheraScreen: K-RAS Mutation Kit (CE-IVD) available for use in European Union on the Roche LightCycler 480 Instrument II More

December 9, 2008
DxS to increase research capabilities with the expansion of the product development team
DxS, a personalised medicine company and market leaders in the provision of companion diagnostics has announced the expansion of its Product Development Team in response to a marked rise in demand for its cancer diagnostics kits in 2008. More

December 2, 2008
DxS and Amgen enter into collaboration to provide a K-RAS companion diagnostic for Vectibix in US
DxS and Amgen enter into collaboration to provide a K-RAS companion diagnostic for Vectibix in the United States. More

November 10, 2008
DxS expand their portfolio of cancer mutation products
DxS expand their portfolio of cancer mutation products, with the launch of a PI3K mutation detection kit. More

November 4, 2008
AltheaDx to offer the DxS K-RAS test for clinical studies
DxS K-RAS test will assist US oncologists in studying patient response to cancer therapies in clinical trials. More

November 3, 2008
DxS grants ETS additional license to provide diagnostics for fuel ethanol testing
DxS Ltd, a personalised medicine company and leaders in the provision of companion diagnostics, has granted ETS Laboratories, the world leader for innovation in wine analysis, an additional license to use DxS Scorpions technology to test for the presence of organisms, which could contaminate biofuel fermentations. More

September 22, 2008
SIRS-Lab and DxS enter into licensing agreement
SIRS-Lab and DxS enter into licensing agreement for the application of Scorpions Technology in Sepsis Test SIQNATURETM More

September 2, 2008
DxS announces license agreement with Wellcome Trust to expand their range of companion diagnostics
DxS, a personalised medicine company and leaders in the provision of companion diagnostics, has signed a non-exclusive global licensing agreement with the Wellcome Trust. More

July 1, 2008
DxS launches cancer mutation kit for K-RAS in Australia
New diagnostic assists clinicians in selecting appropriate cancer therapy for patients More

June 2, 2008
Roche signs exclusive distribution deal with DxS for K-RAS and EGFR cancer mutation tests
Tests identify genetic mutations that can affect patient response to certain cancer drugs More

May 23, 2008
DxS announces plans to expand its manufacturing capacity
Company also announces award of ISO 13485 certification More

Data


26,261
Tech investments
From our Online Data Service
16,961
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Oct 19€3.0MInternet services
Oct 19€6.0MBusiness applications
Oct 18€11.0MConsumer electronics
Oct 18€5.0MBusiness applications
Oct 18€2.3MInternet services
Oct 17€5.9MBiopharmaceuticals
Oct 16€51.0MArtificial Intelligence

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.